|Articles|April 1, 2004
Infliximab effectively treats psoriasis
Washington, D.C. - Infliximab treatment of plaque psoriasis is equally effective regardless of patient gender, body mass index, extent of psoriasis involvement, history of other systemic psoriasis therapy, or whether there is concomitant psoriatic arthritis, according to results of two studies presented here during the 62nd annual meeting of the American Academy of Dermatology.
Advertisement
Newsletter
Like what you’re reading? Subscribe to Dermatology Times for weekly updates on therapies, innovations, and real-world practice tips.
Advertisement
Latest CME
Advertisement
Advertisement
Trending on Dermatology Times
1
Highlighting Major Breakthroughs for Atopic Dermatitis and Psoriasis in 2025
2
First-in-Class Topical GT20029 Demonstrates Promising Phase 2 Efficacy and Tolerability for AGA
3
Balancing Pathophysiology and Patient Lifestyle in Acne Management: Part 2
4
Topicals Demonstrate Targeted Control Across 3 Distinct Atopic Dermatitis Cases
5













